Live feed
Filing
SC 13G
SC 13G0000921895-22-003161·BIOTECHNOLOGY VALUE FUND L P
Schedule 13G ownership disclosure
Kura Oncology Inc
Security class unavailable · CUSIP: 50127T109
Event date: 2022-11-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-22-003161
- Form type
- SC 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Dec 05, 2022
- Reporting period
- Nov 23, 2022
- Description
- Schedule 13G beneficial ownership